Kymera Therapeutics, Inc. Share Price
KYMRKymera Therapeutics, Inc. Stock Performance
Open $87.52 | Prev. Close $86.35 | Circuit Range N/A |
Day Range $87.08 - $88.43 | Year Range $24.72 - $102.81 | Volume 31,469 |
Average Traded $87.82 |
Kymera Therapeutics, Inc. Share Price Chart
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Apr-26 | $87.52 | $87.70 | +0.00% |
17-Apr-26 | $87.52 | $87.70 | +1.88% |
16-Apr-26 | $87.46 | $86.08 | -3.24% |
15-Apr-26 | $90.00 | $88.96 | -0.97% |
14-Apr-26 | $89.00 | $89.83 | +1.56% |
13-Apr-26 | $85.17 | $88.45 | +3.84% |
10-Apr-26 | $86.86 | $85.18 | -2.36% |
FAQs on Kymera Therapeutics, Inc. Share Price
Can I buy Kymera Therapeutics, Inc. shares in India?
What is the share price of Kymera Therapeutics, Inc.?
What is the 5 year returns of Kymera Therapeutics, Inc.?
What are the high & low stock price of Kymera Therapeutics, Inc. today?
What is the 52-week high and low of Kymera Therapeutics, Inc. stock?